One of the challenges in designing
a successful drug-delivery vehicle
is the control over drug release. Toward this, a number of multifunctional
nanoparticles with multiple triggers and complex chemistries have
been developed. To achieve an efficient and maximum therapeutic effect,
a trigger dependent drug-delivery system with sustained release is
desirable. In this paper, we report the use of a combination of thermoresponsive
gold core and polymeric shell nanoparticles that can provide a sustained,
triggered release of doxorubicin, making the system more efficient
compared to individual nanoparticles. The selection of the system
was dependent on the best trigger applicable in biological systems
and a component responsive to that trigger. Because of the best tissue
penetration depth observed for radiofrequency (rf), we chose rf as
a trigger. Whereas the gold nanoparticles (AuNPs) provided hyperthermia
trigger on exposure to rf fields, the thermoresponsiveness was endowed
by poly(N-isopropylacrylamide) (pNIPAm)-based polymer
shells. AuNPs with three different compositions of shells, only pNIPAm
and p(NIPAm-co-NIPMAm) with the ratio of NIPAm/N-(isopropylmethacrylamide) (NIPMAm) 1:1 (pNIPMAm50) and 1:3 (pNIPMAm75), were synthesized. We observed that
the polymer coating on the AuNPs did not affect the heating efficiency
of AuNPs by rf and exhibited a temperature-dependent release of the
chemotherapeutic drug, doxorubicin. The nanoparticles were biocompatible,
stable in biologically relevant media, and were able to show a burst
as well as a sustained release, which was rf-dependent. Interestingly,
we observed that when HeLa cells were treated with doxorubicin-loaded
gold core–polymeric shell NPs and exposed to rf for varying
times, the mixture of the two polymeric shell nanoparticles induced
more cell death as compared to the cells treated with single nanoparticles,
suggesting that such multi-nanoparticle systems can be more efficacious
delivery systems instead of a single multicomponent system.